Clioquinol / hydrocortisone topical Pregnancy and Breastfeeding Warnings

Brand names: Ala-Quin, Corque, Dek-Quin, Dermasorb AF, Hysone, Iodo-HC, Pedi-Cort V, Steroform, Vio-Tex-HC

Clioquinol / hydrocortisone topical Pregnancy Warnings

This drug should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus.

AU TGA pregnancy category: Not formally assigned to a pregnancy category.
US FDA pregnancy category: C

Comments: Use of large amounts or use for prolonged periods of time is not recommended due to possibility of systemic absorption.

Animal studies have revealed evidence of fetal abnormalities with topical corticosteroid exposure (some at low dose levels) and teratogenicity after dermal application of more potent corticosteroids. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Clioquinol / hydrocortisone topical Breastfeeding Warnings

Caution is recommended.
-According to some authorities: Benefit should outweigh risk.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-Only water-miscible creams or gels should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.
-Any product containing a topical corticosteroid should be wiped off thoroughly prior to nursing if it is being applied to the breast or nipple area.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer